The Use of Sodium Glucose Co-transporter-2 Inhibitors in the Treatment of Heart Failure
by Dragana Vlaski, 2024 PharmD Candidate, Timothy H. Vogt, 2024 PharmD Candidate
Heart failure (HF) is a clinical manifestation showing functional impairment and anatomical changes of the heart resulting in inadequate filling or ejection of blood from the heart. Symptoms arise over time as cardiac output declines, making it difficult for the heart to support the body’s blood and oxygen needs. Congestive HF is a highly prevalent, chronic condition that affects a little more than 6 million patients in the United States. The number of people diagnosed with heart failure is increasing and projected to rise 46 percent by 2030. As this condition can get worse if left untreated, it is imperative that patients remain adherent to medications and make any needed changes in diet, physical activity, and lifestyle to have the best quality of life possible.
Keywords: Stroke Volume, Heart Failure, Quality of Life, Diabetes Mellitus, Type 2, Antihypertensive Agents, Cardiotoxins, Cardiovascular Diseases, Heart Ventricles, Hypercholesterolemia, Sodium-Glucose Transporter 2 Inhibitors, Risk Factors, Myocardial Infarction, Disease Progression, Myocardial Ischemia, Heart Valve Diseases, Chronic Disease, Genetic Testing, Healthy Lifestyle, Primary Prevention, Exercise, Cardiomyopathies, Myocardium, Hypertension, Counseling, Delivery of Health Care, Lifestyle, Obesity, Sodium, Diet
Download PDF
2022 November/December Table of Contents
Heart failure (HF) is a clinical manifestation showing functional impairment and anatomical changes of the heart resulting in inadequate filling or ejection of blood from the heart. Symptoms arise over time as cardiac output declines, making it difficult for the heart to support the body’s blood and oxygen needs. Congestive HF is a highly prevalent, chronic condition that affects a little more than 6 million patients in the United States. The number of people diagnosed with heart failure is increasing and projected to rise 46 percent by 2030. As this condition can get worse if left untreated, it is imperative that patients remain adherent to medications and make any needed changes in diet, physical activity, and lifestyle to have the best quality of life possible.
Keywords: Stroke Volume, Heart Failure, Quality of Life, Diabetes Mellitus, Type 2, Antihypertensive Agents, Cardiotoxins, Cardiovascular Diseases, Heart Ventricles, Hypercholesterolemia, Sodium-Glucose Transporter 2 Inhibitors, Risk Factors, Myocardial Infarction, Disease Progression, Myocardial Ischemia, Heart Valve Diseases, Chronic Disease, Genetic Testing, Healthy Lifestyle, Primary Prevention, Exercise, Cardiomyopathies, Myocardium, Hypertension, Counseling, Delivery of Health Care, Lifestyle, Obesity, Sodium, Diet
Download PDF
2022 November/December Table of Contents